K-numberK241132
Device nameARTSMedia Oocyte Aspiration Medium (502020, 502050, 502100)
ApplicantArtsmedia Denmark Aps
Product codeMQL
Device classClass II
Decision dateDec 18, 2024
DecisionSubstantially Equivalent
Regulation884.6180
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

ARTSMedia Oocyte Aspiration Medium is a reproductive media used to retrieve human oocytes (egg cells) through follicular aspiration or flushing during fertility procedures, and can also be used for washing oocytes. The medium consists of physiological salts, energy substrates, buffering agents, human serum albumin, and gentamicin sulfate, provided in sterile glass bottles with an 18-month shelf life when stored at 2–8°C.

Technological characteristics

The subject device formulation differs from the predicate (Medi-Cult Flushing Medium) in specific ingredients and measured parameters including pH (7.2–7.6 vs. not known), osmolality (270–300 mOsm/kg vs. not known), endotoxin specification (<0.25 EU/mL vs. not known), and mouse embryo assay method (1-cell assay vs. two-cell assay). Both devices use aseptic filtration for sterilization and are prescription-use only.

Test standards cited

ISO 10993-5:2009 (cytotoxicity), ISO 10993-10:2021 (sensitization), ISO 10993-23:2021 (vaginal irritation), ISO 13408-1:2008 & A1:2013 (aseptic filtration validation), ISO 13408-2:2018 (aseptic filling), ASTM F1980-21 (accelerated shelf-life aging), ASTM D4169-22 (transportation testing), USP <71>, <85>, <791>, <785>, and <1207.2> (sterility, endotoxin, pH, osmolality, and leak testing).

Substantial equivalence argument

Although the formulations and some technical specifications differ between the subject and predicate devices, the FDA determined that these differences do not raise different questions of safety and effectiveness because both devices share the same intended use (oocyte retrieval and washing), identical prescription-use classification, identical sterilization method, and both demonstrate appropriate biocompatibility, sterility, and embryo compatibility performance through standardized testing. The variations in specific ingredients and measurable parameters reflect acceptable product design choices that do not affect the fundamental safety and efficacy profile.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →